|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.04 USD | -0.76% |
|
+4.19% | -19.14% |
| Apr. 13 | Jefferies Initiates Veracyte at Buy With $45 Price Target | MT |
| Mar. 16 | Veracyte names Kevin Haas as chief development and technology officer | RE |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VERACYTE, INC. | Bio Diagnostics & Testing | -0.76% | +4.19% | -19.14% | +7.18% | -39.62% | 2.7B |  |  | |
- Stock Market
- Equities
- VCYT Stock
- Charts Veracyte, Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
